Brendan Moran

Brendan Moran leads the UK's national peritoneal tumour service and has established one of Europe's largest CRS-HIPEC programs for colorectal peritoneal metastases. He has contributed to national guidelines on peritoneal metastasis management in colorectal cancer and has published prospective outcomes data from the UK peritoneal tumour programme demonstrating long-term survival in carefully selected patients. He also conducts studies on optimal timing of CRS-HIPEC relative to systemic chemotherapy and managing synchronous versus metachronous peritoneal disease.